Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference28 articles.
1. Chemotherapy-induced anaemia in adults: incidence and treatment;Groopman;J Natl Cancer Inst,1999
2. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients;Ludwig;Eur J Cancer,2004
3. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update;Bokemeyer;Eur J Cancer,2007
4. Phase III randomized, double-blind study of epoetin alfa compared with placebo in anaemic patients receiving chemotherapy;Witzig;J Clin Oncol,2005
5. Epoetin alfa treatment results in clinically significant improvements in quality of life in anaemic cancer patients when referenced to the general population;Cella;J Clin Oncol,2003
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recombinant human erythropoietin accelerated the proliferation of non‐small cell lung cancer cell lines and reduced the expression of VEGF, HIF‐1α, and PD‐L1 under a simulated hypoxic environment in vitro;Chronic Diseases and Translational Medicine;2022-03-31
2. Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients;EUR J GYNAECOL ONCOL;2017
3. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model;Health Technology Assessment;2016-02
4. The Effects of Anemia and Blood Transfusion on Patients With Stage III-IV Ovarian Cancer;International Journal of Gynecologic Cancer;2013-11
5. Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial;Medical Oncology;2011-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3